1Reaven, GM (1988) Role of insulin resistance in human disease. Diabetes 37, 1595–1607.
2Ford, ES, Giles, WH & Mokdad, AH (2004) Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27, 2444–2449.
3Grundy, SM (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28, 629–636.
4Festa, A, D'Agostino, R, Howard, G, et al. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102, 42–47.
5Santos, AC, Lopes, C, Guimarães, JT, et al. (2005) Central obesity as a major determinant of increased high sensitivity C-reactive protein in metabolic syndrome. Int J Obes 29, 1452–1456.
6Mckay, DL & Blumberg, JB (2007) Cranberries (Vaccinium macrocarpon) and cardiovascular disease risk factors. Nutr Rev 65, 490–502.
7Wang, Y, Catana, F, Yang, Y, et al. (2002) An LCMS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J Agric Food Chem 50, 431–435.
8Ruel, G & Couillard, C (2007) Evidences of the cardioprotective potential of fruits: the case of cranberries. Mol Nutr Food Res 51, 692–701.
9Pedersen, CB, Kyle, J, Jenkinson, AM, et al. (2000) Effects of blueberry and cranberry juice consumption on the plasma antioxidant capacity of healthy female volunteers. Eur J Clin Nutr 54, 405–408.
10Ruel, G, Pomerleau, S, Couture, P, et al. (2005) Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption. Metabolism 54, 856–861.
11Ruel, G, Pomerleau, S, Couture, P, et al. (2008) Low-calorie cranberry juice supplementation reduces plasma oxidized LDL and cell adhesion molecule concentrations in men. Br J Nutr 99, 352–359.
12Lee, IT, Chan, YC, Lin, CW, et al. (2008) Effect of cranberry extracts on lipid profiles in subjects with type 2 diabetes. Diabet Med 25, 1473–1477.
13Basu, A, Bettsa, NM, Ortiz, JA, et al. (2011) Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome. Nutr Res 31, 190–196.
14Fruchart, JC, Nierman, MC, Stroes, ES, et al. (2004) New risk factors for atherosclerosis and patient risk assessment. Circulation 109, III-15–III-19.
15Ziemke, F & Mantzoros, CS (2010) Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91, Suppl., 258S–261S.
16Salehpour, S, Broujeni, PT & Samani, EN (2009) Leptin, ghrelin, homocysteine and insulin resistance related to polycystic ovary syndrome. Int J Fertil Steril 2, 101–104.
17Song, Z, Zhou, Z, Deaciuc, I, et al. (2008) Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease. Hepatology 47, 867–879.
18Jacobs, DR Jr (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and high blood cholesterol in adults (Adults Treatment Panel III). JAMA 285, 2486–2497.
20Lozovoy, MAB, Simão, ANC, Panis, C, et al. (2011) Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus. Lupus 20, 1250–1259.
21Flecha, BG, Llesuy, S & Boveris, A (1991) Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 10, 93–100.
22Witko-Sarsat, V, Friedlander, M, Khoa, TN, et al. (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161, 2524–2532.
23Selhub, J (2006) The many facets of hyperhomocysteínemia: studies from the Framingham cohorts. J Nutr 136, 1726S–1730S.
24The Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke. A meta-analysis. JAMA 288, 2015–2022.
25Wald, DS, Law, M, Morris, JK, et al. (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202–1208.
26Kawashima, A, Madarame, T, Koike, H, et al. (2007) Four week supplementation with mixed fruit and vegetable juice concentrates increased protective serum antioxidants and folate and decreased plasma homocysteine in Japanese subjects. Asia Pac J Clin Nutr 16, 411–421.
27Paterson, E, Gordon, MH, Niwat, C, et al. (2006) Supplementation with fruit and vegetables soups and beverages increases plasma carotenoid concentrations but does not alter markers of oxidative stress or cardiovascular risk factors. J Nutr 136, 2849–2855.
28Panunzio, MF, Pisano, A, Antoniciello, A, et al. (2003) Supplementation with fruit and vegetable concentrate decreases plasma homocysteine levels in a dietary controlled trial. Nutr Res 23, 1221–1228.
29Samman, S, Sivarajah, G, Man, JC, et al. (2003) A mixed fruit and vegetable concentrate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men. J Nutr 133, 2188–2193.
30Setola, E, Monti, LD, Galluccio, E, et al. (2004) Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 151, 483–489.
31Beattie, J, Crozier, A, Garry, G, et al. (2005) Potential health benefits of berries. Curr Nutr Food Sci 1, 71–86.
32Moat, SJ, Doshi, SN, Lang, D, et al. (2004) Treatment of coronary heart disease with folic acid: is there a future? Am J Physiol Heart Circ Physiol 287, H1–H7.
33Toole, JF, Malinow, MR, Chambless, LE, et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction or death. The vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA 291, 565–575.
34The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. NEJM 354, 1567–1577.
35Bonaa, KH, Njolstad, I, Ueland, PM, et al. (2006) Homocysteine lowering and cardiovascular events after myocardial infarction. N Engl J Med 354, 1578–1588.
36Albert, CM, Cook, NR, Gaziano, JM, et al. (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease. JAMA 299, 2027–2036.
37Ebbing, M, Bleie, O, Ueland, PM, et al. (2008) Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography. JAMA 300, 795–804.
38Yang, Q, Botto, LD, Erickson, D, et al. (2006) Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113, 1335–1343.
39Casas, JP, Bautista, LE, Smeeth, L, et al. (2005) Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 365, 224–232.
40Cronin, S, Furie, KL & Kelly, PJ (2005) Dose-related association of MTHFR 677T allele with risk of ischemic stoke: evidence from a cumulative meta-analyses. Stroke 36, 1581–1587.
41Spence, JD, Bang, H, Chambless, LE, et al. (2005) Vitamin intervention for stroke prevention trial and efficacy analysis. Stroke 36, 2404–2409.
42Lichtenstein, AH & Russell, RM (2005) Essential nutrients: food or supplements? Where should the emphasis be? JAMA 294, 351–358.
43Wellen, KE & Hotamisligil, GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115, 1111–1119.
44Kallio, M, Kolehmainen, DE, Laaksonen, A, et al. (2007) Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study. Am J Clin Nutr 85, 1417–1427.
45Yudkin, JS, Kumari, M, Humphries, SE, et al. (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148, 209–214.
46Tamakoshi, K, Yatsuya, H, Kondo, T, et al. (2003) The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 27, 443–449.
47Yokota, TK, Oritani, I, Takahashi, A, et al. (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96, 1723–1732.
48Ouchi, N, Kihara, S, Arita, Y, et al. (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100, 2473–2476.
49Ouchi, N, Kihara, S, Arita, Y, et al. (2000) Adiponectin, an adipocyte derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 11, 1296–1130.
50Hotta, K, Funahashi, T, Bodkin, NL, et al. (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50, 1126–1133.
51Kern, PA, Ranganathan, S, Li, C, et al. (2001) Adipose tissue tumor necrosis factor and IL-6 expression in human obesity and insulin resistance. Am J Physiol 280, E745–E751.
52Maeda, N, Takahashi, M, Funahashi, T, et al. (2001) PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 53, 2094–2099.
53Arita, Y, Kihara, S, Ouchi, N, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophy Res Commun 257, 79–83.
54Hotta, K, Funahashi, T, Arita, Y, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20, 1595–1599.
55Iwashima, Y, Katsuya, T, Ishikawa, K, et al. (2004) Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43, 1318–1323.
57Martinez-Flores, S, Gutierrez-Fernadez, B, Sanchez-Campos, S, et al. (2005) Quercetin attenuates nuclear factor-kappaB activation and nitric oxide production in interleukin-1beta-activated rat hepatocytes. J Nutr 135, 1359–1365.
58Youdim, KA, McDonald, J, Kalt, W, et al. (2002) Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. J Nutr Biochem 13, 282–288.
59Nijveldt, RJ, Van Nood, E, Van Hoorn, DEC, et al. (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74, 418–425.
60Fried, SK, Bunkin, DA & Greenberg, AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83, 847–850.
61Dichi, I & Simão, ANC (2012) Metabolic syndrome: new targets for an old problem. Expert Opin Ther Targets 16, 147–150.
62McAnulty, LS, Nieman, DC, Dumke, CL, et al. (2011) Effect of blueberry ingestion on natural killer cell counts, oxidative stress, and inflammation prior to and after 2·5 h of running. Appl Physiol Nutr Metab 36, 976–984.
63Bere, E (2007) Wild berries: a good source of omega-3. Eur J Clin Nutr 61, 431–433.
64Itoh, M, Suganami, T, Satoh, N, et al. (2007) Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27, 1918–1925.
65Lara, JJ, Economou, M, Wallace, AM, et al. (2007) Benefits of salmon eating on traditional and novel vascular risk factors in young, non-obese healthy subjects. Atherosclerosis 193, 213–221.
66Nagasawa, A, Fukui, K, Funahashi, T, et al. (2002) Effects of soy protein diet on the expression of adipose genes and plasma adiponectin. Horm Metab Res 34, 635–639.
67Charles, C, Yuskavage, J, Carlson, O, et al. (2009) Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause 16, 395–400.
68Simão, ANC, Lozovoy, MA, Bahls, LD, et al. (2012) Blood pressure decrease with ingestion of a soy product (kinako) or fish oil in women with metabolic syndrome: role of adiponectin and nitric oxide. BJN 108, 1435–1442.
69Sieminska, L, Marek, B, Kos-Kudia, B, et al. (2004) Serum adiponectin in women with polycystic ovary syndrome and its relation to clinical, metabolic and endocrine parameters. J Endocrinol Invest 27, 528–534.
70Côte, J, Caillet, S, Doyon, G, et al. (2010) Bioactive compounds in cranberries and their biological properties. Crit Care Food Sci Nutr 50, 666–679.
71Heinonen, M (2007) Antioxidant activity and antimicrobial effect of berry phenolics – a Finnish perspective. Mol Nutr Food Res 51, 684–691.
72Kahkonen, MP, Hopia, AI, Vuorela, HJ, et al. (1999) Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem 47, 3954–3962.
73Williamson, G & Manach, C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 93 intervention studies. Am J Clin Nutr 81, 243S–255S.
74Badawy, A, State, O, Gawad, SSH, et al. (2006) Plasma homocysteine and PCOS: the missed link. Eur J Obstet Gynecol Rep Biol 5, 112–116.
75Ekmekçi, H, Ekmekçi, B, Erdine, S, et al. (2008) Effects of serum homocysteine and adiponectin levels on platelet aggregation in untreated patients with essential hypertension. J Thromb Thrombolysis 28, 418–424.
76Maahs, DM, Ogden, LG, Kinney, GL, et al. (2005) Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111, 747–753.
77Hayden, MR & Tyagi, SC (2004) Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr J 3, 4–15.
78Dominguez, LJ, Galioto, A, Pineo, A, et al. (2010) Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus. J Am Coll Nutr 29, 1–6.
79Tyagi, N, Sedoris, KC, Steed, M, et al. (2005) Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 289, H2649–H2656.
80Freedman, JE, Parker, C 3rd, Li, L, et al. (2001) Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103, 2792–2798.
81Keevil, JG, Osman, HE, Reed, JD, et al. (2000) Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 130, 53–56.
82O'Byrne, DJ, Devaraj, S, Grundy, SM, et al. (2002) Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults. Am J Clin Nutr 76, 1367–1374.
83Zhu, W, Cheng, KKY, Vanhoutte, PM, et al. (2008) Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci 114, 361–374.